The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Helmex Cat 80 mg/20 mg Chewable Tablets for Cats

80/20 mg/tablet Chewable/dispersible tablet

ZYLAVET Pharmaceuticals LtdVPA10407/002/001

Main Information

Trade NameHelmex Cat 80 mg/20 mg Chewable Tablets for Cats
Active SubstancesPyrantel (as pyrantel embonate)
Strength80/20 mg/tablet
Dosage FormChewable/dispersible tablet
Licence HolderZYLAVET Pharmaceuticals Ltd
Licence NumberVPA10407/002/001

Group Information

ATC CodeQP52AA51 praziquantel, combinations
Therapeutic ClassEndoparasiticide


Licence Issued30/06/2017
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back